These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Sulphated tyrosines mediate association of chemokines and Plasmodium vivax Duffy binding protein with the Duffy antigen/receptor for chemokines (DARC). Choe H; Moore MJ; Owens CM; Wright PL; Vasilieva N; Li W; Singh AP; Shakri R; Chitnis CE; Farzan M Mol Microbiol; 2005 Mar; 55(5):1413-22. PubMed ID: 15720550 [TBL] [Abstract][Full Text] [Related]
6. Independent Origin and Global Distribution of Distinct Plasmodium vivax Duffy Binding Protein Gene Duplications. Hostetler JB; Lo E; Kanjee U; Amaratunga C; Suon S; Sreng S; Mao S; Yewhalaw D; Mascarenhas A; Kwiatkowski DP; Ferreira MU; Rathod PK; Yan G; Fairhurst RM; Duraisingh MT; Rayner JC PLoS Negl Trop Dis; 2016 Oct; 10(10):e0005091. PubMed ID: 27798646 [TBL] [Abstract][Full Text] [Related]
7. Targeting a Reticulocyte Binding Protein and Duffy Binding Protein to Inhibit Reticulocyte Invasion by Plasmodium vivax. Gupta S; Singh S; Popovici J; Roesch C; Shakri AR; Guillotte-Blisnick M; Huon C; Menard D; Chitnis CE Sci Rep; 2018 Jul; 8(1):10511. PubMed ID: 30002416 [TBL] [Abstract][Full Text] [Related]
8. Naturally Acquired Binding-Inhibitory Antibodies to Plasmodium vivax Duffy Binding Protein and Clinical Immunity to Malaria in Rural Amazonians. Nicolete VC; Frischmann S; Barbosa S; King CL; Ferreira MU J Infect Dis; 2016 Nov; 214(10):1539-1546. PubMed ID: 27578850 [TBL] [Abstract][Full Text] [Related]
9. Engagement Rules That Underpin DBL-DARC Interactions for Ingress of Yogavel M; Chhibber-Goel J; Jamwal A; Gupta S; Sharma A Front Mol Biosci; 2018; 5():78. PubMed ID: 30211170 [TBL] [Abstract][Full Text] [Related]
10. Antibodies raised against receptor-binding domain of Plasmodium knowlesi Duffy binding protein inhibit erythrocyte invasion. Singh AP; Puri SK; Chitnis CE Mol Biochem Parasitol; 2002 Apr; 121(1):21-31. PubMed ID: 11985860 [TBL] [Abstract][Full Text] [Related]
11. Acquired antibody responses against Plasmodium vivax infection vary with host genotype for duffy antigen receptor for chemokines (DARC). Maestre A; Muskus C; Duque V; Agudelo O; Liu P; Takagi A; Ntumngia FB; Adams JH; Sim KL; Hoffman SL; Corradin G; Velez ID; Wang R PLoS One; 2010 Jul; 5(7):e11437. PubMed ID: 20664684 [TBL] [Abstract][Full Text] [Related]
12. A Novel Erythrocyte Binding Protein of Plasmodium vivax Suggests an Alternate Invasion Pathway into Duffy-Positive Reticulocytes. Ntumngia FB; Thomson-Luque R; Torres Lde M; Gunalan K; Carvalho LH; Adams JH mBio; 2016 Aug; 7(4):. PubMed ID: 27555313 [TBL] [Abstract][Full Text] [Related]
13. Targeted deletion of Plasmodium knowlesi Duffy binding protein confirms its role in junction formation during invasion. Singh AP; Ozwara H; Kocken CH; Puri SK; Thomas AW; Chitnis CE Mol Microbiol; 2005 Mar; 55(6):1925-34. PubMed ID: 15752210 [TBL] [Abstract][Full Text] [Related]
14. Plasmodium vivax invasion of human erythrocytes inhibited by antibodies directed against the Duffy binding protein. Grimberg BT; Udomsangpetch R; Xainli J; McHenry A; Panichakul T; Sattabongkot J; Cui L; Bockarie M; Chitnis C; Adams J; Zimmerman PA; King CL PLoS Med; 2007 Dec; 4(12):e337. PubMed ID: 18092885 [TBL] [Abstract][Full Text] [Related]
15. Unveiling P. vivax invasion pathways in Duffy-negative individuals. Bouyssou I; El Hoss S; Doderer-Lang C; Schoenhals M; Rasoloharimanana LT; Vigan-Womas I; Ratsimbasoa A; Abate A; Golassa L; Mabilotte S; Kessler P; Guillotte-Blisnick M; Martinez FJ; Chitnis CE; Strouboulis J; Ménard D Cell Host Microbe; 2023 Dec; 31(12):2080-2092.e5. PubMed ID: 38056460 [TBL] [Abstract][Full Text] [Related]
16. Natural acquired inhibitory antibodies to Plasmodium vivax Duffy binding protein (PvDBP-II) equally block erythrocyte binding of homologous and heterologous expressed PvDBP-II on the surface of COS-7 cells. Valizadeh V; Zakeri S; Mehrizi AA; Mirkazemi S; Djadid ND Med Microbiol Immunol; 2016 Feb; 205(1):85-95. PubMed ID: 26243337 [TBL] [Abstract][Full Text] [Related]
17. Preclinical Assessment of Viral Vectored and Protein Vaccines Targeting the Duffy-Binding Protein Region II of Plasmodium Vivax. de Cassan SC; Shakri AR; Llewellyn D; Elias SC; Cho JS; Goodman AL; Jin J; Douglas AD; Suwanarusk R; Nosten FH; Rénia L; Russell B; Chitnis CE; Draper SJ Front Immunol; 2015; 6():348. PubMed ID: 26217340 [TBL] [Abstract][Full Text] [Related]
19. Immunogenicity of a Plasmodium vivax vaccine based on the duffy binding protein formulated using adjuvants compatible for use in humans. Martinez FJ; Guillotte-Blisnick M; Huon C; England P; Popovici J; Laude H; Arowas L; Ungeheuer MN; Reimer JM; Carter D; Reed S; Mukherjee P; Chauhan VS; Chitnis CE Sci Rep; 2023 Aug; 13(1):13904. PubMed ID: 37626150 [TBL] [Abstract][Full Text] [Related]
20. Antibody responses and avidity of naturally acquired anti-Plasmodium vivax Duffy binding protein (PvDBP) antibodies in individuals from an area with unstable malaria transmission. Zakeri S; Babaeekhou L; Mehrizi AA; Abbasi M; Djadid ND Am J Trop Med Hyg; 2011 Jun; 84(6):944-50. PubMed ID: 21633032 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]